泓博医药
(301230)
| 流通市值：19.81亿 | | | 总市值：35.99亿 |
| 流通股本：7686.03万 | | | 总股本：1.40亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 93,011,587.84 | 124,784,163.71 | 108,312,854.23 | 204,296,295.47 |
| 应收票据及应收账款 | 110,820,215.44 | 112,525,231.54 | 101,367,767.47 | 86,248,075.13 |
| 其中：应收票据 | 1,081,641.5 | 1,216,185.25 | 871,910.09 | 715,013.32 |
| 应收账款 | 109,738,573.94 | 111,309,046.29 | 100,495,857.38 | 85,533,061.81 |
| 应收款项融资 | - | 3,643,973.56 | - | - |
| 预付款项 | 4,331,673.19 | 3,241,973.72 | 3,421,367.58 | 2,430,946.79 |
| 其他应收款合计 | 25,418,956.03 | 5,875,244.24 | 5,755,202.51 | 5,055,930.3 |
| 存货 | 77,489,533.84 | 72,645,240.16 | 57,137,195.48 | 61,418,006.89 |
| 其他流动资产 | 39,383,020.45 | 39,928,874.34 | 31,495,304.33 | 31,080,918.3 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 620,478,092.95 | 670,518,249.22 | 701,273,371.03 | 731,324,912.6 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 11,855,486 | 11,981,450.84 | 11,990,176 | 10,084,234.98 |
| 固定资产 | 187,362,294.39 | 180,311,589.55 | 183,227,598.88 | 187,934,998.79 |
| 在建工程 | 8,838,465.74 | 100,935,865.31 | 204,408,896.24 | 199,979,592.66 |
| 使用权资产 | 165,132,107.5 | 170,859,160 | 176,586,212.5 | 182,313,265 |
| 无形资产 | 8,397,221.12 | 8,483,400.33 | 8,596,909.97 | 8,710,419.61 |
| 长期待摊费用 | 328,417,326.95 | 246,668,736.2 | 150,279,260.4 | 155,332,632.75 |
| 递延所得税资产 | 24,967,147.83 | 19,955,185.03 | 14,197,086.25 | 10,290,504.32 |
| 其他非流动资产 | 2,713,007.07 | 1,466,629.2 | 379,429 | 1,193,362.06 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 737,683,056.6 | 740,662,016.46 | 749,665,569.24 | 755,839,010.17 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,358,161,149.55 | 1,411,180,265.68 | 1,450,938,940.27 | 1,487,163,922.77 |
| 流动负债: | | | | |
| 短期借款 | 12,326,751.4 | 19,666,670.89 | 23,258,158.74 | 15,921,295.25 |
| 应付票据及应付账款 | 76,491,612.68 | 104,674,778.09 | 99,315,130.5 | 114,612,962.7 |
| 其中：应付票据 | 5,227,213.77 | 2,100,000 | 3,077,436 | 8,278,970.2 |
| 应付账款 | 71,264,398.91 | 102,574,778.09 | 96,237,694.5 | 106,333,992.5 |
| 预收款项 | 1,955,247.78 | 1,955,115.49 | 1,913,728.01 | 1,951,499.84 |
| 合同负债 | 5,154,241.03 | 2,182,279.14 | 2,304,132.73 | 2,222,525.09 |
| 应付职工薪酬 | 27,792,807.89 | 24,403,050.48 | 22,728,218.78 | 28,803,550.47 |
| 应交税费 | 2,375,716.61 | 4,422,676.87 | 4,320,404.17 | 4,751,997.8 |
| 其他应付款合计 | 3,033,739.09 | 3,090,290.1 | 2,484,154.57 | 3,363,286.32 |
| 一年内到期的非流动负债 | 20,158,021.91 | 19,913,089.13 | 19,501,416.54 | 18,759,919.38 |
| 其他流动负债 | 1,368,308.92 | 1,371,399.5 | 1,049,401.27 | 834,712.21 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 150,656,447.31 | 181,679,349.69 | 176,874,745.31 | 191,221,749.06 |
| 非流动负债: | | | | |
| 租赁负债 | 156,484,585.23 | 161,616,876.04 | 166,664,755.35 | 171,673,082.68 |
| 预计负债 | 3,181,464.79 | 2,235,350.61 | 1,152,951.81 | 3,098,653.55 |
| 递延收益 | 80,000 | - | - | - |
| 递延所得税负债 | 3,210,844.03 | 2,692,083.42 | 2,892,867.83 | 3,625,770.95 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 162,956,894.05 | 166,544,310.07 | 170,710,574.99 | 178,397,507.18 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 313,613,341.36 | 348,223,659.76 | 347,585,320.3 | 369,619,256.24 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 139,586,605 | 139,586,605 | 107,622,666 | 107,622,666 |
| 资本公积 | 766,810,139.45 | 766,810,139.45 | 798,774,078.45 | 798,774,078.45 |
| 减:库存股 | 53,075,305.42 | 35,352,317.52 | 17,858,707.12 | - |
| 其他综合收益 | -4,824.99 | -51,900.47 | - | - |
| 盈余公积 | 24,852,529.51 | 24,852,529.51 | 24,852,529.51 | 24,852,529.51 |
| 未分配利润 | 166,378,664.64 | 167,111,549.95 | 189,963,053.13 | 186,295,392.57 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,044,547,808.19 | 1,062,956,605.92 | 1,103,353,619.97 | 1,117,544,666.53 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,044,547,808.19 | 1,062,956,605.92 | 1,103,353,619.97 | 1,117,544,666.53 |
| 负债和股东权益合计 | 1,358,161,149.55 | 1,411,180,265.68 | 1,450,938,940.27 | 1,487,163,922.77 |
| 公告日期 | 2024-10-28 | 2024-08-28 | 2024-04-26 | 2024-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |